Literature DB >> 23707067

Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.

Christian Arsov1, Nikolaus Becker, Boris A Hadaschik, Markus Hohenfellner, Kathleen Herkommer, Jürgen E Gschwend, Florian Imkamp, Markus A Kuczyk, Gerald Antoch, Glen Kristiansen, Roswitha Siener, Axel Semjonow, Freddie C Hamdy, Hans Lilja, Andrew J Vickers, Fritz H Schröder, Peter Albers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23707067     DOI： 10.1016/j.eururo.2013.05.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

Review 1.  Serum markers in prostate cancer detection.

Authors:  Ola Bratt; Hans Lilja
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

Review 2.  [Structure of biobanks for urological research].

Authors:  G Hatiboglu; J Huber; E Herpel; I V Popeneciu; J Nyarangi-Dix; D Teber; B A Hadaschik; S Pahernik; S Duensing; M Hohenfellner
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

3.  [Effect of performing a single PSA screening : The CAP trial].

Authors:  R Al-Monajjed; C Arsov; P Albers
Journal:  Urologe A       Date:  2018-09       Impact factor: 0.639

4.  [Self-concept and erectile dysfunction in 45-year-old men : Results of a corollary study of the PROBASE trial].

Authors:  A M Kögel; A Dinkel; B Marten-Mittag; J Baron; P Albers; C Arsov; B Hadaschik; M Hohenfellner; F Imkamp; M Kuczyk; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2016-10       Impact factor: 0.639

Review 5.  Prostate cancer screening-when to start and how to screen?

Authors:  Kimia Kohestani; Marina Chilov; Sigrid V Carlsson
Journal:  Transl Androl Urol       Date:  2018-02

6.  PSA screening - for whom and when?

Authors:  Peter Albers
Journal:  Asian J Androl       Date:  2017-09-05       Impact factor: 3.285

7.  Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Authors:  Evan Kovac; Sigrid V Carlsson; Hans Lilja; Jonas Hugosson; Michael W Kattan; Erik Holmberg; Andrew J Stephenson
Journal:  JAMA Netw Open       Date:  2020-01-03

Review 8.  Personalized strategies in population screening for prostate cancer.

Authors:  Sebastiaan Remmers; Monique J Roobol
Journal:  Int J Cancer       Date:  2020-06-03       Impact factor: 7.396
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.